Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allergies: early-phase trial registry
4 of 7 indexed Allergies trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Allergies: 7 US clinical trials tracked, 4 recruiting.
Allergies is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Andrew D. Luster, M.D.,Ph.D., running 2 of these trials.
Enrollment posture brief
Registry condition allergies
OPEN 4 | RECR 57% | LATE 0 | EARLY 4 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Allergies lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allergies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allergies is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Allergies research.
Andrew D. Luster, M.D.,Ph.D. accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Allergies enrolment sits around 168 participants.
Median target enrolment is 168 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Allergies research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
NCT05635266
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Johns Hopkins University
NCT07059091
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
University of Maryland, Baltimore
NCT06002685
Omalizumab Weight-Based Dosing Efficacy Trial
Massachusetts General Hospital
NCT06943534
T Cell Effector and Regulatory Mechanisms in Asthma
Andrew D. Luster, M.D.,Ph.D.
NCT01612936
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Andrew D. Luster, M.D.,Ph.D.
NCT01711593
Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)
University of Michigan
NCT04644783
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Allergies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allergies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allergies page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Allergies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Andrew D. Luster, M.D.,Ph.D. sponsors the most Allergies trials on record, review their full trial history before evaluating a specific study. See Andrew D. Luster, M.D.,Ph.D.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allergies condition card totals 7 registered trials; most-linked intervention Blood test assay; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.